Rezultati pretraživanja
  1. prije 46 minuta

    Good summary of 's planned spinoff and separation intentions - Dividing into two companies - One R&D-focused company - One consumer health company through JV with (+maybe the prescription derm business) - Cost is £2.4B over 2 years

    Prikaži ovu nit
  2. prije 1 sat
  3. prije 1 sat

    Clinical Trials Innovation Programme will bring together CROs, CMOs, and Senior from , and industries globally to discuss, reflect on and develop their ideas.

  4. prije 3 sata
  5. prije 4 sata

    Learn the 10 most common false assumptions made during biopharma partnering deals from expert business development consultant, Linda Pullan, PhD of . Read the blog >> |

  6. Jefferson Institute for Bioprocessing and  have partnered to create the JIB-BCG Digital Demonstrator for digital innovation in operations. The demonstrator is the first of its kind in the US. Learn more ▶️

  7. prije 7 sati

    Chromatography Media Specialist position open for New York, New Jersey & Connecticut ! Click here to learn more & apply ---> Tell them that AKTAguy sent you! 😎

  8. prije 7 sati

    merger looking profitable or not from SH standpoint w/Timber Pharmaceuticals bringing 20mil to the table. What's your thoughts on this merger with a price target of $2.25.

  9. prije 7 sati

    To explore the evolving role of the CIO and find best practices for a successful digital health strategy, and spoke with CIOs from the top and companies. Download this to learn more:

  10. prije 8 sati
  11. prije 8 sati
  12. At ClearLight Biotechnologies we enable modern heroes to see more biology and explore further with Tru3D™. Get Started with CLARITY and Tru3D.

  13. prije 9 sati
  14. - CURE has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s leading pharmaceutical groups specialized in medicinal cannabis products.

  15. prije 9 sati

    is proud to be a part of the and B4.0 Alliance Innovation Centre, helping companies implement through ThingWorx to solve Advanced Fill Finish use cases and deliver value

  16. prije 9 sati

    By focusing on high touch services that can help enhance patient outcomes, and life sciences companies can overcome the market access challenges faced by orphan drugs. Download our white paper to learn more:

  17. prije 9 sati

    The industry provides 196,000 high-skill, high-wage jobs in Texas. See new video featuring @ TXManufacturers

  18. prije 10 sati

    . to spin-off & into unnamed company to achieve $1.5B in operating efficiencies by 2024 NewCo also to snag legacy brands in , , & some markets

  19. prije 10 sati

    Almost 50 Non-Oncology Drugs Found to Kill Cancer Cells:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.